Mounjaro weight loss drug shows 'game-changing' UK results
A landmark study presented in Vienna shows the diabetes drug tirzepatide (Mounjaro) leads to unprecedented weight loss in NHS patients, offering new hope in the fight against obesity.
A landmark study presented in Vienna shows the diabetes drug tirzepatide (Mounjaro) leads to unprecedented weight loss in NHS patients, offering new hope in the fight against obesity.
The NHS is rolling out a powerful new 4mg weekly injection of semaglutide, a 'game-changer' in weight loss treatment, as part of a major strategy to tackle the nation's obesity epidemic.
Exclusive: Diabetes and weight loss patients face financial strain as Eli Lilly's new Mounjaro KwikPens hit the market without the anticipated price reduction, maintaining a premium cost for the identical medication.
Exclusive: Desperate UK diabetics face a devastating health crisis as they are cut off from the 'miracle' weight-loss drug Mounjaro (tirzepatide) due to soaring costs and an NHS postcode lottery, with patients fearing for their lives.
A British mother's life-changing journey from 30st to 8st using diabetes drug Mounjaro. Discover how this remarkable transformation saved her marriage and restored her health against all odds.
Exclusive: The NHS is now prescribing powerful diabetes medications Ozempic and Mounjaro for weight loss, sparking a massive surge in demand and a fierce debate over ethics and supply.
An NHS administrator reveals how she lost four stone using a controversial cost-cutting method to obtain diabetes drug Mounjaro for weight loss, as doctors issue serious safety warnings.
The NHS in England is set to provide the highly effective Mounjaro (tirzepatide) weight-loss injection, hailed as a major breakthrough in fighting obesity and related diseases like type 2 diabetes.
Shocking new data reveals a stark postcode lottery for the diabetes and weight loss drug Mounjaro (tirzepatide) in England, with patients in some areas almost completely unable to access it on the NHS despite being eligible.
The NHS is dramatically expanding the availability of prescription weight-loss injections, hailed as a 'game-changer' in treating obesity. This major rollout could benefit hundreds of thousands more patients across England.
The NHS in England is set to provide the weight-loss drug Mounjaro (tirzepatide) to thousands, following a landmark deal that could save millions and free up GP capacity.
Exclusive investigation reveals the staggering postcode lottery and soaring costs of life-changing obesity drugs like Mounjaro and Wegovy, as the NHS struggles to cope with unprecedented demand.
Groundbreaking UK study reveals a new diabetes medication, Mounjaro (tirzepatide), achieves significantly greater weight loss and superior cardiovascular benefits compared to Ozempic, revolutionising obesity treatment.
A groundbreaking UK study reveals the diabetes drug Mounjaro (tirzepatide) isn't just for weight loss—it dramatically cuts the risk of heart attacks and strokes, heralding a new era in preventative medicine.
Groundbreaking British research warns that popular weight-loss injections like Ozempic and Mounjaro may significantly increase hospitalisation risks for heart failure patients. Experts call for urgent review of prescription guidelines.
Ex-Culture Minister Ed Vaizey urges the NHS to widely prescribe revolutionary weight loss injections, calling them a potential 'miracle' for public health and a solution to the obesity crisis.
Exclusive: Medical experts warn of a deepening postcode lottery and a surge in the illegal black market for weight-loss jabs as NHS England struggles with supply and soaring demand for GLP-1 drugs.
Groundbreaking UK research finds semaglutide-based drugs, popular for weight loss, significantly improve symptoms and physical limitations in obese heart failure patients, offering a new potential treatment avenue.
Supermarket giant Asda has dramatically cut the price of the sought-after weight loss drug Mounjaro, making the weekly injection more affordable for Brits seeking treatment.
Eli Lilly drastically cuts the price of its Mounjaro injection in the UK, making the revolutionary diabetes and weight loss treatment more accessible. The move follows a landmark NHS supply deal.
The MHRA has officially approved the weight-loss injection Mounjaro (tirzepatide) for the UK market, with a set price, marking a significant new option in the nation's battle against obesity.
The UK cost of the revolutionary Mounjaro weight loss injection has been unveiled. Discover the price, availability, and how it compares to NHS prescriptions and private clinics.
Exclusive: A perfect storm of NHS price hikes and soaring demand for the 'miracle' drug tirzepatide triggers a national shortage, leaving thousands of diabetics and weight-loss patients in limbo. Fears grow as stockpiling begins.
The weight loss drug Mounjaro (tirzepatide) is launching in the UK, challenging Ozempic. Experts warn of potential shortages and urge prescriptions for those with clinical need, not casual use.
An NHS weight loss expert explains the 'Ozempic burp' and other embarrassing gastrointestinal side effects of drugs like Mounjaro and Ozempic, why they happen, and practical strategies to manage them effectively.
The UK's medicines watchdog approves the weight loss injection Mounjaro (tirzepatide), offering a powerful new option in the fight against obesity. Discover its price, how it works, and where to get it.
Eli Lilly suspends shipments of obesity drug Mounjaro to the UK, triggering a major price surge and leaving thousands of patients in limbo amid supply chain restructuring.
A British woman's life-changing weight loss journey using Mounjaro injections has been thrown into turmoil after a dramatic price increase made the drug unaffordable, forcing her to confront the return of debilitating 'food noise'.
Exclusive medical advice reveals how celebratory meals while on the weight-loss jab Mounjaro (tirzepatide) can lead to severe gastrointestinal distress, 'sulphur burps', and hospitalisation risks.
UK health officials issue a critical safety alert for the type 2 diabetes drug Mounjaro (tirzepatide), linking it to severe stomach paralysis and intestinal blockages. Patients are urged to recognise the warning signs.